Protara Therapeutics Inc (TARA)
3.10
-0.64
(-17.11%)
USD |
NASDAQ |
May 17, 16:00
3.10
0.00 (0.00%)
After-Hours: 20:00
Protara Therapeutics Cash from Investing (Quarterly): 23.10M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 23.10M |
| December 31, 2023 | 14.52M |
| September 30, 2023 | 6.378M |
| June 30, 2023 | 22.35M |
| March 31, 2023 | 9.86M |
| December 31, 2022 | -18.34M |
| September 30, 2022 | 19.05M |
| June 30, 2022 | 13.50M |
| March 31, 2022 | 0.745M |
| Date | Value |
|---|---|
| December 31, 2021 | 1.889M |
| September 30, 2021 | 0.107M |
| June 30, 2021 | -1.941M |
| March 31, 2021 | -98.25M |
| December 31, 2020 | -0.511M |
| September 30, 2020 | -0.132M |
| June 30, 2020 | 0.006M |
| March 31, 2020 | 3.472M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-98.25M
Minimum
Mar 2021
23.10M
Maximum
Mar 2024
-0.2472M
Average
1.889M
Median
Dec 2021
Cash from Investing (Quarterly) Benchmarks
| AngioDynamics Inc | 29.40M |
| Regulus Therapeutics Inc | -78.54M |
| Bio-Path Holdings Inc | 0.00 |
| Outset Medical Inc | -59.03M |
| NovaBay Pharmaceuticals Inc | 1.068M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -10.38M |
| Cash from Financing (Quarterly) | -0.076M |
| Free Cash Flow | -35.05M |
| Free Cash Flow Per Share (Quarterly) | -0.9088 |
| Free Cash Flow Yield | -99.84% |